Because EHMTs can interact with LSD1, and LSD1 can function as a transcription activator inducing oncogenic reprogramming in prostate cancer cells (8, 31), we investigated whether EHMTs and LSD1 shared target genes. This evidence concerns the gene KDM1A and prostate cancer.